RGT 2.90% 35.5¢ argent biopharma limited

Ann: Trading Halt, page-21

  1. 1,377 Posts.
    lightbulb Created with Sketch. 1
    I loathe to agree with Lape, but trials are expensive...

    They'll need to be funded somehow, hopefully they're run in collaboration with a pharma and they're covering expenses. But that's probably wishful thinking at this stage.

    Also, hopefully the trial results are transferable to Australia to affect licences and permissions. I'm not sure how overseas trials are treated here.

    Anyone know more?

    Cheers
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.